Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Energy
(240/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Boehringer Ingelheim
Jan 16, 2018
FDA approves new indication for Gilotrif® in EGFR mutation-positive NSCLC
Jan 15, 2018
Global Immunology Market 2018-2022: 51 Molecules - 22 Molecules in Phase II, 4 Molecules in Phase III, 16 Molecules in Phase I, and 9 in Phase I/Il Clinical Trials
Jan 10, 2018
Boehringer Ingelheim's Respimat Inhaler Awarded Arthritis Foundation's Ease of Use Commendation
Jan 04, 2018
Global Asthma and COPD Market 2017-2025 - Market Value Expected to Reach $56 Billion
Jan 04, 2018
Rewind Therapeutics Secures 15.2 M EURO to Develop Novel Remyelination Therapies
Dec 20, 2017
Knowledge Of Biosimilars: Survey Of 100+ U.S. Rheumatologists Shows Familiarity But Need For Further Education
Dec 19, 2017
Evox Therapeutics to Collaborate with Boehringer Ingelheim on Exosome-Mediated Drug Delivery
Dec 19, 2017
Global Veterinary Therapeutics Market to Mark CAGR of 6.0% Over Next 10 Years - MarketResearch.biz
Dec 15, 2017
Global Anti-idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2027
Dec 12, 2017
Boehringer Ingelheim initiates real-world study of treatment sequencing in EGFR mutation-positive lung cancer
Dec 11, 2017
Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017
Dec 07, 2017
Holiday Program Brings Hope Home to Lung Cancer Patients
Dec 04, 2017
Boehringer Ingelheim Invests $80 Million to Expand Animal Vaccine Manufacturing Capacity in the U.S.
Nov 13, 2017
Jardiance® reduced risk of cardiovascular death in adults with type 2 diabetes and peripheral artery disease
Nov 13, 2017
New RE-VERSE AD(TM) Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery
Nov 10, 2017
Boehringer Ingelheim Presents New Data for Pradaxa® and its Specific Reversal Agent Idarucizumab (Praxbind®) at AHA Scientific Sessions 2017
Nov 10, 2017
Results from six-month lung imaging study showed slowing of fibrotic progression in patients with IPF treated with Ofev® versus placebo
Nov 09, 2017
Diversity in clinical trials critical to refining medicines and therapies
Nov 08, 2017
CellSight Technologies Announces Strategic Collaboration With Boehringer Ingelheim to Develop a New Technology for Monitoring Anti-tumor T-Cell Activation
Nov 07, 2017
Medical Affairs Reputations: Type 2 Diabetes Mellitus (EU5)
‹‹
Page 9
››
Latest News
Apr 19, 2024
ICE Announces Record Trading Activity in Murban Crude as ICE Futures Abu Dhabi Marks Third Anniversary
Apr 19, 2024
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
Apr 19, 2024
Two Top Rating Agencies Reaffirm Metropolitan’s Strong Credit Ratings
Apr 19, 2024
Mativ Announces Conference Call to Discuss First Quarter 2024 Results
Apr 19, 2024
LSI Industries Acquires EMI Industries, Expanding Store Fixtures and Food Service Equipment Business
Apr 19, 2024
Anue Water Technologies Adds Four New Channel Partners to Serve Wastewater Treatment Customers in California...
Apr 19, 2024
Kermit Facility Operational Update
Apr 19, 2024
Israel targets army position in Syria: ministry
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events